Aspira Womens Health Inc (AWH)
2.95
-0.13
(-4.22%)
USD |
NASDAQ |
May 10, 16:00
2.95
0.00 (0.00%)
After-Hours: 20:00
Aspira Womens Health Revenue (Quarterly): 2.13M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.13M |
| September 30, 2023 | 2.217M |
| June 30, 2023 | 2.491M |
| March 31, 2023 | 2.316M |
| December 31, 2022 | 2.153M |
| September 30, 2022 | 2.072M |
| June 30, 2022 | 2.066M |
| March 31, 2022 | 1.893M |
| December 31, 2021 | 1.851M |
| September 30, 2021 | 1.666M |
| June 30, 2021 | 1.799M |
| March 31, 2021 | 1.496M |
| December 31, 2020 | 1.446M |
| September 30, 2020 | 1.239M |
| June 30, 2020 | 0.746M |
| March 31, 2020 | 1.22M |
| December 31, 2019 | 1.308M |
| September 30, 2019 | 1.285M |
| June 30, 2019 | 1.142M |
| March 31, 2019 | 0.803M |
| December 31, 2018 | 0.922M |
| September 30, 2018 | 0.774M |
| June 30, 2018 | 0.708M |
| March 31, 2018 | 0.649M |
| December 31, 2017 | 0.798M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.699M |
| June 30, 2017 | 0.898M |
| March 31, 2017 | 0.726M |
| December 31, 2016 | 0.805M |
| September 30, 2016 | 0.623M |
| June 30, 2016 | 0.709M |
| March 31, 2016 | 0.505M |
| December 31, 2015 | 0.361M |
| September 30, 2015 | 0.33M |
| June 30, 2015 | 0.535M |
| March 31, 2015 | 0.951M |
| December 31, 2014 | 1.569M |
| September 30, 2014 | 0.323M |
| June 30, 2014 | 0.324M |
| March 31, 2014 | 0.305M |
| December 31, 2013 | 1.585M |
| September 30, 2013 | 0.33M |
| June 30, 2013 | 0.323M |
| March 31, 2013 | 0.328M |
| December 31, 2012 | 1.142M |
| September 30, 2012 | 0.319M |
| June 30, 2012 | 0.321M |
| March 31, 2012 | 0.312M |
| December 31, 2011 | 0.868M |
| September 30, 2011 | 0.32M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.746M
Minimum
Jun 2020
2.491M
Maximum
Jun 2023
1.712M
Average
1.799M
Median
Jun 2021
Revenue (Quarterly) Benchmarks
| Bruker Corp | 721.70M |
| Azenta Inc | 154.32M |
| Harvard Bioscience Inc | 28.15M |
| Bionano Genomics Inc | 10.72M |
| Akoya Biosciences Inc | 26.49M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.089M |
| Total Expenses (Quarterly) | 6.265M |
| EPS Diluted (Quarterly) | -0.30 |
| Enterprise Value | 37.69M |
| Gross Profit Margin (Quarterly) | 57.23% |
| Profit Margin (Quarterly) | -145.0% |
| Earnings Yield | -60.68% |
| Normalized Earnings Yield | -66.48 |